Previous 10 | Next 10 |
SAN FRANCISCO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team wil...
Unity Biotechnology (NASDAQ: UBX ) has appointed Lynne Sullivan as chief financial officer, effective September 1, 2020. More news on: Unity Biotechnology, Inc., Healthcare stocks news, Stocks on the move, Read more ...
SAN FRANCISCO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced the appointment of Lynne Sullivan to the perman...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . . Tech carried the major U.S. stock averages higher on Friday, with Apple, alone, adding more than $100B to its market cap. The impasse o...
Unity Biotechnology suffers setback for lead drug candidate UBX0101 Unity Biotechnology Inc. ( UBX ) reported its 12-week data from Phase 2 clinical study in patients with painful osteoarthritis of the knee. The data did not show any statistically significant difference between any arm ...
Gainers: MICT (NASDAQ: MICT ) +52% . More news on: MICT, Inc., RISE Education Cayman Ltd, Forward Industries, Inc., Stocks on the move, , Read more ...
Let's have a look at the case of Unity Biotechnology (UBX), because this is a story that won't get so many headlines. Unity has been investigating a really interesting but high-risk idea. It's in the anti-aging field, so those two adjectives sort of apply by definition, and it's the hypothes...
Shares of Unity Biotechnology (NASDAQ: UBX) fell over 63% today after the company announced disappointing results from a clinical trial involving its lead drug candidate, UBX0101. At the 12-week mark of a phase 2 study, the pipeline asset failed to meet its primary endpoint in allevia...
Gainers: Comstock Mining (NYSEMKT: LODE ) +128% . More news on: Comstock Mining Inc., RISE Education Cayman Ltd, IMARA Inc., Stocks on the move, , Read more ...
Unity Biotechnology (NASDAQ: UBX ) -51% on stumble with lead drug . More news on: Unity Biotechnology, Inc., Interpace Biosciences, Inc., Taiwan Liposome Company, Ltd., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Unity Biotechnology Inc. Company Name:
UBX Stock Symbol:
NASDAQ Market:
Unity Biotechnology Inc. Website:
SOUTH SAN FRANCISCO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2024. "Our team r...
SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that the Company will present two poster presentations at t...
SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the ongoing Phase 2b ASPIRE study of UBX1325 has been e...